Spero Therapeutics, Inc. (SPRO)
USD 0.54
(-7.78%)
USD 0.54
(-7.78%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 96.36 Million USD | 104.9% |
| 2022 | 47.03 Million USD | 174.42% |
| 2021 | 17.13 Million USD | 129.72% |
| 2020 | -57.67 Million USD | 5.51% |
| 2019 | -61.03 Million USD | -103.99% |
| 2018 | -29.91 Million USD | 3.14% |
| 2017 | -30.89 Million USD | -18.82% |
| 2016 | -25.99 Million USD | -236245.45% |
| 2015 | -11 Thousand USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 9.26 Million USD | -87.09% |
| 2024 Q2 | 6.01 Million USD | -35.09% |
| 2023 Q3 | 25.36 Million USD | 390.82% |
| 2023 FY | 96.36 Million USD | 104.9% |
| 2023 Q4 | 71.78 Million USD | 183.02% |
| 2023 Q1 | -8.23 Million USD | -117.93% |
| 2023 Q2 | -8.72 Million USD | -5.86% |
| 2022 FY | 47.03 Million USD | 174.42% |
| 2022 Q2 | -7.27 Million USD | -3046.15% |
| 2022 Q3 | -6.27 Million USD | 13.73% |
| 2022 Q4 | 45.94 Million USD | 831.77% |
| 2022 Q1 | 247 Thousand USD | -91.0% |
| 2021 Q2 | 5.14 Million USD | -29.48% |
| 2021 Q1 | 7.3 Million USD | 282.8% |
| 2021 FY | 17.13 Million USD | 129.72% |
| 2021 Q4 | 2.74 Million USD | -10.44% |
| 2021 Q3 | 3.06 Million USD | -40.48% |
| 2020 Q4 | 1.9 Million USD | -52.27% |
| 2020 FY | -57.67 Million USD | 5.51% |
| 2020 Q1 | 169 Thousand USD | -75.72% |
| 2020 Q2 | 1.72 Million USD | 921.89% |
| 2020 Q3 | 3.99 Million USD | 131.33% |
| 2019 Q2 | 2.15 Million USD | -43.37% |
| 2019 FY | -61.03 Million USD | -103.99% |
| 2019 Q4 | 696 Thousand USD | 304.65% |
| 2019 Q3 | 172 Thousand USD | -92.02% |
| 2019 Q1 | 3.8 Million USD | 125.0% |
| 2018 Q1 | 1.15 Million USD | 16.11% |
| 2018 Q2 | 463 Thousand USD | -59.84% |
| 2018 Q3 | 658 Thousand USD | 42.12% |
| 2018 Q4 | 1.69 Million USD | 157.14% |
| 2018 FY | -29.91 Million USD | 3.14% |
| 2017 Q1 | 140 Thousand USD | -58.21% |
| 2017 FY | -30.89 Million USD | -18.82% |
| 2017 Q2 | 249 Thousand USD | 77.86% |
| 2017 Q3 | 597 Thousand USD | 139.76% |
| 2017 Q4 | 993 Thousand USD | 66.33% |
| 2016 Q3 | - USD | 0.0% |
| 2016 FY | -25.99 Million USD | -236245.45% |
| 2016 Q4 | 335 Thousand USD | 0.0% |
| 2015 FY | -11 Thousand USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| AbCellera Biologics Inc. | 38.02 Million USD | -153.433% |
| Alkermes plc | 1.37 Billion USD | 92.99% |
| Agenus Inc. | 139.61 Million USD | 30.976% |
| Aptorum Group Limited | -1.11 Million USD | 8745.289% |
| Ardelyx, Inc. | 106.66 Million USD | 9.65% |
| Dyadic International, Inc. | 922.95 Thousand USD | -10341.223% |
| Eton Pharmaceuticals, Inc. | 21.06 Million USD | -357.566% |
| Lantern Pharma Inc. | -174.84 Thousand USD | 55216.876% |
| Inhibikase Therapeutics, Inc. | -13.35 Million USD | 821.434% |
| Novavax, Inc. | 639.93 Million USD | 84.941% |
| Janux Therapeutics, Inc. | -46.83 Million USD | 305.743% |
| Pyxis Oncology, Inc. | -2 Million USD | 4918.4% |
| TransCode Therapeutics, Inc. | -516.74 Thousand USD | 18749.007% |
| Ocuphire Pharma, Inc. | 19.04 Million USD | -406.055% |
| Outlook Therapeutics, Inc. | -44.18 Thousand USD | 218186.358% |
| Madrigal Pharmaceuticals, Inc. | -527 Thousand USD | 18386.148% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| SELLAS Life Sciences Group, Inc. | - USD | -Infinity% |
| Syros Pharmaceuticals, Inc. | -98.21 Million USD | 198.117% |
| Barinthus Biotherapeutics plc | 802 Thousand USD | -11915.96% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | 117621.951% |
| Xeris Biopharma Holdings, Inc. | 135.26 Million USD | 28.758% |
| Clearside Biomedical, Inc. | 7.87 Million USD | -1124.343% |
| C4 Therapeutics, Inc. | -96.95 Million USD | 199.4% |
| Alnylam Pharmaceuticals, Inc. | 1.51 Billion USD | 93.651% |
| AlloVir, Inc. | -398 Thousand USD | 24313.065% |
| Arrowhead Pharmaceuticals, Inc. | 240.73 Million USD | 59.969% |
| VYNE Therapeutics Inc. | 424 Thousand USD | -22628.302% |
| Bicycle Therapeutics plc | -129.52 Million USD | 174.404% |
| BioXcel Therapeutics, Inc. | 120 Thousand USD | -80206.667% |
| ChromaDex Corporation | 50.78 Million USD | -89.776% |
| Chimerix, Inc. | 324 Thousand USD | -29643.21% |
| Corbus Pharmaceuticals Holdings, Inc. | -31.16 Million USD | 409.192% |
| Caribou Biosciences, Inc. | -77.59 Million USD | 224.189% |
| CRISPR Therapeutics AG | 240.95 Million USD | 60.006% |
| Precision BioSciences, Inc. | 40.47 Million USD | -138.11% |
| Fate Therapeutics, Inc. | -98.16 Million USD | 198.171% |
| Fortress Biotech, Inc. | 57.85 Million USD | -66.574% |
| Fortress Biotech, Inc. | 57.85 Million USD | -66.574% |
| HOOKIPA Pharma Inc. | 16.57 Million USD | -481.336% |
| ImmuCell Corporation | 4.39 Million USD | -2092.033% |
| IDEAYA Biosciences, Inc. | -106.12 Million USD | 190.808% |
| Immix Biopharma, Inc. | -5468.00 USD | 1762499.415% |
| Incyte Corporation | 3.44 Billion USD | 97.199% |
| Innoviva, Inc. | 261.06 Million USD | 63.087% |
| IO Biotech, Inc. | -756 Thousand USD | 12847.09% |
| Jaguar Health, Inc. | 7.72 Million USD | -1147.644% |
| Keros Therapeutics, Inc. | -664 Thousand USD | 14613.253% |
| Ligand Pharmaceuticals Incorporated | 119.75 Million USD | 19.528% |
| ContextLogic Inc. | 59 Million USD | -63.336% |
| MiMedx Group, Inc. | 266.84 Million USD | 63.886% |
| MEI Pharma, Inc. | 49.32 Million USD | -95.366% |
| NextCure, Inc. | -3.68 Million USD | 2715.852% |
| Onconetix, Inc. | -1.12 Million USD | 8649.591% |
| Oncternal Therapeutics, Inc. | -28.96 Million USD | 432.671% |
| Opthea Limited | 21.72 Thousand USD | -443583.241% |
| Psyence Biomedical Ltd. | -240.00 USD | 40153433.333% |
| Vaxcyte, Inc. | -75 Million USD | 228.491% |
| PDS Biotechnology Corporation | -57.32 Thousand USD | 168205.223% |
| Precigen, Inc. | 106 Thousand USD | -90813.208% |
| Pharming Group N.V. | 220.1 Million USD | 56.217% |
| Phathom Pharmaceuticals, Inc. | 515 Thousand USD | -18612.233% |
| Pieris Pharmaceuticals, Inc. | 1 Million USD | -9450.842% |
| PureTech Health plc | -1.6 Million USD | 6111.728% |
| Rigel Pharmaceuticals, Inc. | 109.77 Million USD | 12.211% |
| Avidity Biosciences, Inc. | -181.4 Million USD | 153.122% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Sangamo Therapeutics, Inc. | -45.32 Million USD | 312.616% |
| Sol-Gel Technologies Ltd. | -21.98 Million USD | 538.295% |
| Acelyrin, Inc. | -115 Thousand USD | 83898.261% |
| Salarius Pharmaceuticals, Inc. | -10.05 Thousand USD | 958890.17% |
| Summit Therapeutics Inc. | -2.05 Million USD | 4800.878% |
| Sensei Biotherapeutics, Inc. | -571 Thousand USD | 16977.058% |
| Senti Biosciences, Inc. | -2.68 Million USD | 3691.8% |
| Stoke Therapeutics, Inc. | 4.05 Million USD | -2278.869% |
| Elevation Oncology, Inc. | -39 Thousand USD | 247197.436% |
| Alaunos Therapeutics, Inc. | -4.79 Million USD | 2108.504% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | 2544.618% |
| Entrada Therapeutics, Inc. | 29.12 Million USD | -230.832% |
| VistaGen Therapeutics, Inc. | 496 Thousand USD | -19329.032% |
| Kintara Therapeutics, Inc. | -55 Thousand USD | 175314.545% |
| Wave Life Sciences Ltd. | 104.09 Million USD | 7.427% |
| Seer, Inc. | 7.02 Million USD | -1271.396% |
| Verrica Pharmaceuticals Inc. | 4.37 Million USD | -2101.188% |
| Aadi Bioscience, Inc. | 21.54 Million USD | -347.287% |
| ESSA Pharma Inc. | -118.49 Thousand USD | 81429.384% |
| GlycoMimetics, Inc. | -143.3 Thousand USD | 67348.658% |
| GT Biopharma, Inc. | - USD | -Infinity% |
| Inhibrx Biosciences, Inc. | 609 Thousand USD | -15723.974% |
| Akebia Therapeutics, Inc. | 120.47 Million USD | 20.009% |
| Catalyst Pharmaceuticals, Inc. | 313.67 Million USD | 69.277% |
| Longboard Pharmaceuticals, Inc. | -5000.00 USD | 1927460.0% |
| Orchestra BioMed Holdings, Inc. | 2.57 Million USD | -3643.901% |
| Alzamend Neuro, Inc. | -50.74 Thousand USD | 190025.108% |
| Sorrento Therapeutics, Inc. | 29.38 Million USD | -227.927% |
| TRACON Pharmaceuticals, Inc. | -232 Thousand USD | 41637.931% |
| Viracta Therapeutics, Inc. | -492 Thousand USD | 19686.992% |
| Rocket Pharmaceuticals, Inc. | -7.09 Million USD | 1457.678% |
| Aptose Biosciences Inc. | -474.54 Thousand USD | 20407.452% |
| ZyVersa Therapeutics, Inc. | -10.4 Thousand USD | 926715.385% |
| Soligenix, Inc. | 97.31 Thousand USD | -98930.942% |
| Century Therapeutics, Inc. | -10.8 Million USD | 991.553% |
| Kura Oncology, Inc. | -849 Thousand USD | 11450.766% |
| TScan Therapeutics, Inc. | -67.1 Million USD | 243.61% |
| Intensity Therapeutics, Inc. | -147 Thousand USD | 65656.463% |
| Ocean Biomedical, Inc. | - USD | -Infinity% |
| CytomX Therapeutics, Inc. | 99.03 Million USD | 2.697% |
| Autolus Therapeutics plc | -4.86 Million USD | 2080.029% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| EyePoint Pharmaceuticals, Inc. | 41.38 Million USD | -132.852% |
| Eterna Therapeutics Inc. | -168 Thousand USD | 57461.905% |
| Adaptive Biotechnologies Corporation | 94.72 Million USD | -1.737% |
| GRI Bio, Inc. | 10.84 Million USD | -788.922% |
| Xenetic Biosciences, Inc. | 2.53 Million USD | -3694.037% |
| Tenaya Therapeutics, Inc. | -8.68 Million USD | 1209.336% |
| IGM Biosciences, Inc. | -211.66 Million USD | 145.53% |
| INmune Bio, Inc. | 155 Thousand USD | -62072.903% |
| Heron Therapeutics, Inc. | 61.93 Million USD | -55.585% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 6497.701% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 14961.193% |
| Entero Therapeutics, Inc. | -29.27 Thousand USD | 329293.141% |
| Milestone Pharmaceuticals Inc. | 402 Thousand USD | -23872.139% |
| X4 Pharmaceuticals, Inc. | -1.99 Million USD | 4928.056% |
| Atara Biotherapeutics, Inc. | -313 Thousand USD | 30888.498% |
| Coherus BioSciences, Inc. | 94.46 Million USD | -2.019% |
| Verastem, Inc. | -62 Thousand USD | 155532.258% |
| Abeona Therapeutics Inc. | 2.43 Million USD | -3857.618% |
| Pliant Therapeutics, Inc. | -261 Thousand USD | 37022.605% |
| Tonix Pharmaceuticals Holding Corp. | 3.02 Million USD | -3083.614% |
| Histogen Inc. | 3.76 Million USD | -2456.859% |
| Aprea Therapeutics, Inc. | 576.17 Thousand USD | -16625.358% |
| Surrozen, Inc. | -27.23 Million USD | 453.904% |
| Organovo Holdings, Inc. | -5.38 Million USD | 1888.235% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Ovid Therapeutics Inc. | -1.2 Million USD | 8098.141% |
| Panbela Therapeutics, Inc. | -25.64 Million USD | 475.748% |
| CASI Pharmaceuticals, Inc. | 20.05 Million USD | -380.59% |
| Cadrenal Therapeutics, Inc. Common Stock | -1980.00 USD | 4867170.707% |
| Centessa Pharmaceuticals plc | 6.06 Million USD | -1488.547% |
| Hepion Pharmaceuticals, Inc. | -67.13 Thousand USD | 143652.159% |
| Arcturus Therapeutics Holdings Inc. | 154.79 Million USD | 37.743% |
| BioRestorative Therapies, Inc. | 145.8 Thousand USD | -65996.022% |
| Apollomics, Inc. | 127 Thousand USD | -75780.315% |
| Amarin Corporation plc | 165.54 Million USD | 41.786% |
| Mesoblast Limited | -9.81 Million USD | 1081.844% |
| Turnstone Biologics Corp. | 16.5 Million USD | -483.836% |
| Kymera Therapeutics, Inc. | -110.48 Million USD | 187.22% |
| Synaptogenix, Inc. | -6347.00 USD | 1518423.617% |
| Tiziana Life Sciences Ltd | -51 Thousand USD | 189056.863% |
| Aurinia Pharmaceuticals Inc. | 161.36 Million USD | 40.279% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Exelixis, Inc. | 1.75 Billion USD | 94.517% |
| Better Therapeutics, Inc. | -2.72 Million USD | 3631.257% |
| Nurix Therapeutics, Inc. | -112.16 Million USD | 185.919% |
| Apellis Pharmaceuticals, Inc. | 338.08 Million USD | 71.496% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 844840.533% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Aridis Pharmaceuticals, Inc. | - USD | -Infinity% |
| Gritstone bio, Inc. | -6.26 Million USD | 1639.425% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 8797.473% |
| TNF Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avid Bioservices, Inc. | 7.31 Million USD | -1216.862% |
| Insmed Incorporated | 239.63 Million USD | 59.786% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| MediWound Ltd. | 3.57 Million USD | -2593.348% |
| OmniAb, Inc. | 14.66 Million USD | -557.04% |
| Alector, Inc. | -95.05 Million USD | 201.383% |
| Seres Therapeutics, Inc. | 125.62 Million USD | 23.287% |
| Checkpoint Therapeutics, Inc. | -43.46 Million USD | 321.724% |
| Zai Lab Limited | 170.9 Million USD | 43.612% |
| Revance Therapeutics, Inc. | 81.87 Million USD | -17.698% |
| Aura Biosciences, Inc. | -1.29 Million USD | 7541.544% |
| Lyell Immunopharma, Inc. | 130 Thousand USD | -74029.231% |
| Immunic, Inc. | -111 Thousand USD | 86918.018% |
| Tarsus Pharmaceuticals, Inc. | 15.85 Million USD | -507.847% |
| Veracyte, Inc. | 248.14 Million USD | 61.165% |
| InMed Pharmaceuticals Inc. | -6.98 Billion USD | 101.379% |
| FibroGen, Inc. | 128.9 Million USD | 25.24% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| Adial Pharmaceuticals, Inc. | -564.00 USD | 17086624.823% |
| Sonnet BioTherapeutics Holdings, Inc. | -11.66 Million USD | 925.996% |
| Jazz Pharmaceuticals plc | 3.39 Billion USD | 97.165% |
| Cyclacel Pharmaceuticals, Inc. | 389 Thousand USD | -24673.265% |
| Amylyx Pharmaceuticals, Inc. | 355.34 Million USD | 72.88% |
| TG Therapeutics, Inc. | 219.1 Million USD | 56.018% |
| Galecto, Inc. | -830 Thousand USD | 11710.602% |
| Calithera Biosciences, Inc. | -1.38 Million USD | 7057.978% |
| Fortrea Holdings Inc. | 424 Million USD | 77.272% |
| KalVista Pharmaceuticals, Inc. | -86.16 Million USD | 211.839% |
| Aptevo Therapeutics Inc. | -567 Thousand USD | 17096.12% |
| XBiotech Inc. | -1.74 Million USD | 5625.688% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 8797.473% |
| Lyra Therapeutics, Inc. | -46.47 Million USD | 307.372% |
| Foghorn Therapeutics Inc. | -75.53 Million USD | 227.582% |
| Y-mAbs Therapeutics, Inc. | 73.4 Million USD | -31.286% |
| Theravance Biopharma, Inc. | 16.8 Million USD | -473.517% |
| Ultragenyx Pharmaceutical Inc. | 389.04 Million USD | 75.229% |
| Metagenomi, Inc. Common Stock | -49.64 Million USD | 294.106% |
| Vaxxinity, Inc. | -2.23 Million USD | 4413.697% |
| BioCryst Pharmaceuticals, Inc. | 326.75 Million USD | 70.507% |
| Gain Therapeutics, Inc. | -11.32 Million USD | 951.019% |
| Cartesian Therapeutics, Inc. | 24.45 Million USD | -294.127% |
| NexImmune, Inc. | -1.02 Million USD | 9502.013% |
| Creative Medical Technology Holdings, Inc. | 5400.00 USD | -1784492.593% |
| Marker Therapeutics, Inc. | -7.1 Million USD | 1456.215% |
| Regeneron Pharmaceuticals, Inc. | 11.3 Billion USD | 99.147% |
| Chemomab Therapeutics Ltd. | -66.82 Thousand USD | 144305.187% |
| Scopus BioPharma Inc. | - USD | -Infinity% |
| RAPT Therapeutics, Inc. | -3.55 Million USD | 2813.827% |
| Ainos, Inc. | -253.73 Thousand USD | 38080.081% |
| Pluri Inc. | 322 Thousand USD | -29827.95% |
| Prothena Corporation plc | -129.2 Million USD | 174.588% |
| Adaptimmune Therapeutics plc | 50.42 Million USD | -91.116% |
| Celularity Inc. | 6.75 Million USD | -1326.617% |
| Rallybio Corporation | -150 Thousand USD | 64345.333% |
| Cue Biopharma, Inc. | -32.6 Million USD | 395.544% |
| MeiraGTx Holdings plc | 287 Thousand USD | -33477.7% |
| Omeros Corporation | -69.77 Million USD | 238.105% |
| Humacyte, Inc. | -76.55 Million USD | 225.889% |
| Immunocore Holdings plc | 248.39 Million USD | 61.203% |
| Cocrystal Pharma, Inc. | -15.16 Million USD | 735.296% |
| Cidara Therapeutics, Inc. | 62.38 Million USD | -54.48% |
| Blueprint Medicines Corporation | 236.58 Million USD | 59.267% |
| CalciMedica, Inc. | -58 Thousand USD | 166251.724% |
| Cabaletta Bio, Inc. | -1.42 Million USD | 6857.924% |
| Marinus Pharmaceuticals, Inc. | 29.05 Million USD | -231.674% |
| Scholar Rock Holding Corporation | -2.84 Million USD | 3488.467% |
| Sana Biotechnology, Inc. | -30.86 Million USD | 412.224% |
| Pulmatrix, Inc. | -8.22 Million USD | 1272.36% |
| Elicio Therapeutics, Inc. | -1.17 Million USD | 8336.581% |
| Vigil Neuroscience, Inc. | -399 Thousand USD | 24252.381% |
| Intellia Therapeutics, Inc. | -398.79 Million USD | 124.165% |
| Adlai Nortye Ltd. American Depositary Shares | 2.77 Million USD | -3371.989% |
| Cytokinetics, Incorporated | -322.59 Million USD | 129.873% |
| Eloxx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | -11078.221% |
| Protara Therapeutics, Inc. | -341 Thousand USD | 28360.411% |
| Vor Biopharma Inc. | -3.49 Million USD | 2859.679% |
| Roivant Sciences Ltd. | 109.23 Million USD | 11.779% |
| Evogene Ltd. | 1.39 Million USD | -6788.349% |
| ProKidney Corp. | -3.16 Million USD | 3140.959% |
| Applied Therapeutics, Inc. | -43.91 Million USD | 319.457% |
| Hoth Therapeutics, Inc. | - USD | -Infinity% |
| BridgeBio Pharma, Inc. | 6.85 Million USD | -1305.396% |
| CorMedix Inc. | -205.56 Thousand USD | 46980.26% |
| BioLineRx Ltd. | 1.1 Million USD | -8597.473% |
| Tango Therapeutics, Inc. | -78.67 Million USD | 222.495% |
| Galectin Therapeutics Inc. | -33 Thousand USD | 292124.242% |
| Atai Life Sciences N.V. | -5000.00 USD | 1927460.0% |
| Renovaro Biosciences Inc. | -121.85 Thousand USD | 79181.561% |
| Aerovate Therapeutics, Inc. | -96 Thousand USD | 100483.333% |
| Zentalis Pharmaceuticals, Inc. | -1.38 Million USD | 7037.941% |
| Sagimet Biosciences Inc. | 2 Million USD | -4718.4% |
| MediciNova, Inc. | 979.7 Thousand USD | -9736.43% |
| Praxis Precision Medicines, Inc. | -84.31 Million USD | 214.29% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 102017.403% |
| GeoVax Labs, Inc. | -20.72 Million USD | 565.079% |
| Axsome Therapeutics, Inc. | 244.53 Million USD | 60.591% |
| Biomea Fusion, Inc. | -4.2 Million USD | 2393.93% |
| PTC Therapeutics, Inc. | 872.33 Million USD | 88.953% |
| Mereo BioPharma Group plc | 7.42 Million USD | -1197.711% |
| Cullinan Oncology, Inc. | -310 Thousand USD | 31186.452% |
| Syndax Pharmaceuticals, Inc. | -12 Thousand USD | 803166.667% |
| Absci Corporation | -41.84 Million USD | 330.276% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 1927460.0% |
| 4D Molecular Therapeutics, Inc. | -76.37 Million USD | 226.181% |
| Dyne Therapeutics, Inc. | -2.46 Million USD | 4015.807% |
| Kiniksa Pharmaceuticals, Ltd. | 213.73 Million USD | 54.912% |
| Ventyx Biosciences, Inc. | -941 Thousand USD | 10341.02% |
| Allakos Inc. | -6.14 Million USD | 1669.256% |
| Imunon, Inc. | -720 Thousand USD | 13484.351% |
| Fulcrum Therapeutics, Inc. | -68.99 Million USD | 239.672% |
| Corcept Therapeutics Incorporated | 475.89 Million USD | 79.75% |
| BioAtla, Inc. | -103.73 Million USD | 192.902% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 844840.533% |
| Bio-Path Holdings, Inc. | -178 Thousand USD | 54239.326% |
| Allogene Therapeutics, Inc. | -242.81 Million USD | 139.687% |
| Larimar Therapeutics, Inc. | -311 Thousand USD | 31086.495% |
| XOMA Corporation | 3.86 Million USD | -2395.934% |
| Kezar Life Sciences, Inc. | -70.08 Million USD | 237.502% |
| Cara Therapeutics, Inc. | 14.79 Million USD | -551.399% |
| aTyr Pharma, Inc. | -2.38 Million USD | 4135.511% |
| Aligos Therapeutics, Inc. | 12.46 Million USD | -673.419% |
| Akero Therapeutics, Inc. | -29 Thousand USD | 332403.448% |
| Viridian Therapeutics, Inc. | -1 Million USD | 9660.317% |
| Eliem Therapeutics, Inc. | - USD | -Infinity% |
| EyeGate Pharmaceuticals, Inc. | 13.00 USD | -741292207.692% |
| Akari Therapeutics, Plc | -4000.00 USD | 2409300.0% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Halozyme Therapeutics, Inc. | 636.89 Million USD | 84.869% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -49393.601% |
| UroGen Pharma Ltd. | 73.35 Million USD | -31.377% |
| Sutro Biopharma, Inc. | -26.69 Million USD | 461.01% |
| ZIVO Bioscience, Inc. | 11.61 Thousand USD | -829943.066% |
| Orgenesis Inc. | -5.72 Million USD | 1783.284% |
| Entera Bio Ltd. | -56 Thousand USD | 172185.714% |
| GH Research PLC | -315 Thousand USD | 30693.016% |
| Lisata Therapeutics, Inc. | -189 Thousand USD | 51088.36% |
| Reneo Pharmaceuticals, Inc. | -525 Thousand USD | 18455.81% |
| Xencor, Inc. | -85.26 Million USD | 213.028% |
| 60 Degrees Pharmaceuticals, Inc. | -220.97 Thousand USD | 43709.968% |
| Replimune Group, Inc. | -2.65 Million USD | 3729.68% |
| Coeptis Therapeutics Holdings, Inc. | -1 Million USD | 9724.904% |
| Vanda Pharmaceuticals Inc. | 177.84 Million USD | 45.813% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -49393.601% |
| Portage Biotech Inc. | -54 Thousand USD | 178559.259% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 102017.403% |
| Olema Pharmaceuticals, Inc. | -377 Thousand USD | 25661.804% |
| OncoCyte Corporation | 413 Thousand USD | -23233.656% |
| Qualigen Therapeutics, Inc. | -4495.00 USD | 2143993.215% |
| Processa Pharmaceuticals, Inc. | -222.00 USD | 43409109.009% |
| Purple Biotech Ltd. | -196 Thousand USD | 49267.347% |
| CollPlant Biotechnologies Ltd. | 8.96 Million USD | -974.576% |
| scPharmaceuticals Inc. | 9.78 Million USD | -885.156% |
| ProMIS Neurosciences, Inc. | -10.44 Million USD | 1022.627% |
| HilleVax, Inc. | -2.15 Million USD | 4569.759% |
| NeuroSense Therapeutics Ltd. | -97 Thousand USD | 99448.454% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | -15 Thousand USD | 642382.058% |
| Neumora Therapeutics, Inc. Common Stock | -668 Thousand USD | 14526.347% |
| Atossa Therapeutics, Inc. | -23 Thousand USD | 419091.304% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | -7506.16 USD | 1283952.196% |
| Savara Inc. | -44.26 Million USD | 317.722% |
| Curis, Inc. | 9.81 Million USD | -882.244% |
| Daré Bioscience, Inc. | 2.76 Million USD | -3379.59% |
| Carmell Therapeutics Corporation | -124.78 Thousand USD | 77325.374% |
| Titan Pharmaceuticals, Inc. | -1.72 Million USD | 5673.626% |
| Achieve Life Sciences, Inc. | -228 Thousand USD | 42366.667% |
| BeiGene, Ltd. | 2.07 Billion USD | 95.364% |
| Kiromic BioPharma, Inc. | -2.79 Million USD | 3546.761% |
| Revolution Medicines, Inc. Warrant | -399.66 Million USD | 124.112% |
| Protagonist Therapeutics, Inc. | 56.68 Million USD | -69.997% |
| Erasca, Inc. | -3.73 Million USD | 2682.208% |
| bluebird bio, Inc. | -4.03 Million USD | 2491.266% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 341612.51% |
| BioMarin Pharmaceutical Inc. | 1.9 Billion USD | 94.94% |
| DBV Technologies S.A. | 15.72 Million USD | -512.716% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 341612.51% |
| Moderna, Inc. | 2.15 Billion USD | 95.528% |
| Vincerx Pharma, Inc. | -915 Thousand USD | 10632.022% |
| Fresh Tracks Therapeutics, Inc. | 8 Million USD | -1103.697% |
| Molecular Templates, Inc. | 50.39 Million USD | -91.225% |
| Acrivon Therapeutics, Inc. Common Stock | -536 Thousand USD | 18079.104% |
| Travere Therapeutics, Inc. | 133.78 Million USD | 27.97% |
| Monte Rosa Therapeutics, Inc. | -6.22 Million USD | 1648.827% |
| Spruce Biosciences, Inc. | -39.34 Million USD | 344.943% |
| Celldex Therapeutics, Inc. | -111.12 Million USD | 186.718% |
| Cogent Biosciences, Inc. | -3.58 Million USD | 2785.842% |
| MacroGenics, Inc. | 50.52 Million USD | -90.726% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Adicet Bio, Inc. | -6.09 Million USD | 1680.321% |
| Prime Medicine, Inc. | -147.9 Million USD | 165.155% |
| Aditxt, Inc. | -111.66 Thousand USD | 86404.854% |
| Adagene Inc. | 18.11 Million USD | -432.082% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 488 Thousand USD | -19647.541% |
| Maravai LifeSciences Holdings, Inc. | 140.2 Million USD | 31.265% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 157.83 Million USD | 38.944% |
| SciSparc Ltd. | 2.19 Million USD | -4288.342% |
| Vericel Corporation | 135.57 Million USD | 28.92% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 384817.953% |
| Minerva Neurosciences, Inc. | -30.98 Thousand USD | 311145.123% |
| Generation Bio Co. | -73.91 Million USD | 230.384% |
| Astria Therapeutics, Inc. | - USD | -Infinity% |
| Black Diamond Therapeutics, Inc. | -437 Thousand USD | 22152.174% |
| Arcutis Biotherapeutics, Inc. | 54.61 Million USD | -76.437% |
| Invivyd, Inc. | -2.02 Million USD | 4851.874% |
| Relay Therapeutics, Inc. | -300.84 Million USD | 132.033% |
| Quoin Pharmaceuticals, Ltd. | -103.43 Thousand USD | 93264.988% |
| Artelo Biosciences, Inc. | - USD | -Infinity% |
| 2seventy bio, Inc. | 98.28 Million USD | 1.953% |
| ADMA Biologics, Inc. | 88.21 Million USD | -9.238% |
| Clene Inc. | 533 Thousand USD | -17980.3% |
| Capricor Therapeutics, Inc. | 24.1 Million USD | -299.715% |
| Boundless Bio, Inc. Common Stock | -957 Thousand USD | 10169.801% |
| GeoVax Labs, Inc. | -20.72 Million USD | 565.079% |
| Recursion Pharmaceuticals, Inc. | 1.98 Million USD | -4747.485% |
| Citius Pharmaceuticals, Inc. | -194.31 Thousand USD | 49693.446% |
| Contineum Therapeutics, Inc. Class A Common Stock | 49.8 Million USD | -93.491% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| Finch Therapeutics Group, Inc. | -7.09 Million USD | 1458.827% |
| ALX Oncology Holdings Inc. | -836 Thousand USD | 11627.273% |
| Vir Biotechnology, Inc. | 83.41 Million USD | -15.528% |
| Evaxion Biotech A/S | 73.11 Thousand USD | -131708.732% |
| Ocular Therapeutix, Inc. | 53.16 Million USD | -81.272% |
| Verve Therapeutics, Inc. | -173.18 Million USD | 155.644% |
| Trevena, Inc. | 1.45 Million USD | -6523.23% |
| Surrozen, Inc. | -27.23 Million USD | 453.904% |
| Tyra Biosciences, Inc. | -353 Thousand USD | 27399.717% |
| Cingulate Inc. | -582.91 Thousand USD | 16631.999% |
| Galmed Pharmaceuticals Ltd. | -31 Thousand USD | 310964.516% |
| Unity Biotechnology, Inc. | -19.69 Million USD | 589.202% |
| Tenax Therapeutics, Inc. | -7570.00 USD | 1273125.099% |
| Terns Pharmaceuticals, Inc. | -881 Thousand USD | 11038.479% |
| ACADIA Pharmaceuticals Inc. | 680.7 Million USD | 85.843% |
| Connect Biopharma Holdings Limited | -988 Thousand USD | 9853.846% |
| Clearmind Medicine Inc. | -56.34 Thousand USD | 171141.142% |
| Kronos Bio, Inc. | 1.37 Million USD | -6923.907% |
| Bolt Biotherapeutics, Inc. | -53.66 Million USD | 279.57% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Viking Therapeutics, Inc. | -292 Thousand USD | 33102.74% |
| Statera Biopharma, Inc. | -488.31 Thousand USD | 19834.843% |
| ImmunityBio, Inc. | -17.89 Million USD | 638.67% |
| Korro Bio, Inc. | -3.63 Million USD | 2754.766% |
| Kineta, Inc. | 5.43 Million USD | -1673.753% |
| BioVie Inc. | -229.37 Thousand USD | 42112.931% |
| Codexis, Inc. | 57.33 Million USD | -68.082% |
| Celularity Inc. | 6.75 Million USD | -1326.617% |
| Crinetics Pharmaceuticals, Inc. | 4.01 Million USD | -2301.395% |
| Celcuity Inc. | -142.77 Thousand USD | 67597.829% |
| Virax Biolabs Group Limited | 50.59 Thousand USD | -190388.239% |
| Cibus, Inc. | 1.42 Million USD | -6676.934% |
| Eledon Pharmaceuticals, Inc. | -374 Thousand USD | 25866.845% |
| eFFECTOR Therapeutics, Inc. | -22.91 Million USD | 520.472% |
| IN8bio, Inc. | -2.5 Million USD | 3953.179% |
| Kodiak Sciences Inc. | -25.94 Million USD | 471.403% |
| Annexon, Inc. | -3.26 Million USD | 3049.74% |
| Adverum Biotechnologies, Inc. | -2.04 Million USD | 4814.677% |
| Assembly Biosciences, Inc. | -41.73 Million USD | 330.893% |
| Avalo Therapeutics, Inc. | 640 Thousand USD | -14957.5% |
| Ionis Pharmaceuticals, Inc. | 778.51 Million USD | 87.622% |
| Eyenovia, Inc. | - USD | -Infinity% |
| Puma Biotechnology, Inc. | 172.95 Million USD | 44.281% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Xilio Therapeutics, Inc. | -1.9 Million USD | 5172.0% |
| Arcellx, Inc. | 108.27 Million USD | 11.0% |
| Cardiff Oncology, Inc. | -32.36 Million USD | 397.717% |
| Enanta Pharmaceuticals, Inc. | 79.2 Million USD | -21.671% |
| Regulus Therapeutics Inc. | -21.15 Million USD | 555.598% |
| Moolec Science SA | -143.3 Thousand USD | 67346.781% |
| Acumen Pharmaceuticals, Inc. | -42.31 Million USD | 327.723% |
| Geron Corporation | -123.5 Million USD | 178.029% |
| LAVA Therapeutics N.V. | 3.28 Million USD | -2831.792% |
| Royalty Pharma plc | 1.79 Billion USD | 94.628% |
| Atea Pharmaceuticals, Inc. | -70.09 Million USD | 237.492% |
| Greenwich LifeSciences, Inc. | -3612.00 USD | 2668095.57% |
| TFF Pharmaceuticals, Inc. | 231.39 Thousand USD | -41547.255% |
| Mersana Therapeutics, Inc. | -111.41 Million USD | 186.495% |
| Humacyte, Inc. | -76.55 Million USD | 225.889% |
| Structure Therapeutics Inc. | -949.17 Thousand USD | 10252.828% |
| 89bio, Inc. | -273 Thousand USD | 35399.634% |
| PMV Pharmaceuticals, Inc. | -1.25 Million USD | 7766.508% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Genelux Corporation | -848 Thousand USD | 11464.151% |
| Trevi Therapeutics, Inc. | -123 Thousand USD | 78447.967% |
| Lexicon Pharmaceuticals, Inc. | 1.11 Million USD | -8511.975% |
| Notable Labs, Ltd. | 113 Thousand USD | -85181.416% |
| Liquidia Corporation | 14.6 Million USD | -560.055% |
| Mustang Bio, Inc. | -2.22 Million USD | 4431.146% |
| Immunovant, Inc. | -231 Thousand USD | 41817.749% |
| Quantum-Si incorporated | 488 Thousand USD | -19647.541% |
| Arbutus Biopharma Corporation | -55.55 Million USD | 273.452% |
| DiaMedica Therapeutics Inc. | -30 Thousand USD | 321326.667% |
| Vera Therapeutics, Inc. | 1.86 Million USD | -5075.51% |
| Acasti Pharma Inc. | -11 Thousand USD | 876172.727% |
| MiNK Therapeutics, Inc. | -204.61 Thousand USD | 47196.771% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 14961.193% |
| Xenon Pharmaceuticals Inc. | -167.51 Million USD | 157.529% |
| Elevai Labs, Inc. Common Stock | 1.13 Million USD | -8393.716% |
| NeuroBo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Tempest Therapeutics, Inc. | -381 Thousand USD | 25393.438% |
| Soleno Therapeutics, Inc. | -1.95 Million USD | 5021.757% |
| PepGen Inc. | -1.18 Million USD | 8239.189% |
| Moleculin Biotech, Inc. | -127 Thousand USD | 75980.315% |
| United Therapeutics Corporation | 2.07 Billion USD | 95.345% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | 520.876% |
| Solid Biosciences Inc. | -76.56 Million USD | 225.868% |
| BriaCell Therapeutics Corp. | -82.58 Thousand USD | 116792.297% |
| Immuneering Corporation | -764.13 Thousand USD | 12711.335% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | 66.26 Thousand USD | -145330.4% |
| Belite Bio, Inc | -399 Thousand USD | 24252.381% |
| XOMA Corporation | 3.86 Million USD | -2395.934% |
| ARS Pharmaceuticals, Inc. | -20.03 Million USD | 580.974% |
| Bionomics Limited | -434.44 Thousand USD | 22281.66% |
| Apogee Therapeutics, Inc. | - USD | -Infinity% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 9072.812% |
| uniQure N.V. | 2.21 Million USD | -4250.7% |
| Cassava Sciences, Inc. | -89.42 Million USD | 207.766% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | -92.06 Million USD | 204.669% |
| Forte Biosciences, Inc. | -9000.00 USD | 1070855.556% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | -835 Thousand USD | 11641.078% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| FibroBiologics, Inc. Common Stock | -437 Thousand USD | 22152.174% |
| Altimmune, Inc. | -65.37 Million USD | 247.413% |
| Amicus Therapeutics, Inc. | 362.03 Million USD | 73.381% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 9072.812% |
| Compugen Ltd. | 31.45 Million USD | -206.368% |
| Peak Bio, Inc. | 367.76 Thousand USD | -26103.405% |
| Zevra Therapeutics, Inc. | 24.51 Million USD | -293.082% |
| Benitec Biopharma Inc. | 108 Thousand USD | -89129.63% |
| Spyre Therapeutics, Inc. | -78 Thousand USD | 123648.718% |
| NKGen Biotech, Inc. Common Stock | -1.2 Million USD | 8110.64% |
| Zura Bio Limited | - USD | -Infinity% |
| PolyPid Ltd. | -1.82 Million USD | 5389.133% |
| Aileron Therapeutics, Inc. | -119 Thousand USD | 81081.513% |
| NKGen Biotech, Inc. Warrants | -1.2 Million USD | 8110.64% |
| Instil Bio, Inc. | -4.75 Million USD | 2126.241% |
| argenx SE | 1.1 Billion USD | 91.306% |
| Immunome, Inc. | -8.9 Million USD | 1181.936% |
| Compass Therapeutics, Inc. | -1.89 Million USD | 5198.836% |
| Verona Pharma plc | -679.62 Thousand USD | 14279.605% |
| enGene Holdings Inc. Warrants | -175 Thousand USD | 55167.429% |
| Shattuck Labs, Inc. | -2.38 Million USD | 4140.587% |
| CervoMed Inc. | -1.29 Million USD | 7549.443% |
| LENZ Therapeutics, Inc. | -2.4 Million USD | 4103.656% |
| Plus Therapeutics, Inc. | -4.77 Million USD | 2117.333% |
| Dianthus Therapeutics, Inc. | 2.47 Million USD | -3799.96% |
| Moolec Science SA | -143.3 Thousand USD | 67346.781% |
| Enveric Biosciences, Inc. | -408.03 Thousand USD | 23717.871% |
| Inovio Pharmaceuticals, Inc. | -2.67 Million USD | 3707.224% |
| AnaptysBio, Inc. | 14.78 Million USD | -551.972% |
| Design Therapeutics, Inc. | -537 Thousand USD | 18045.624% |
| Leap Therapeutics, Inc. | -427 Thousand USD | 22668.618% |
| NeurAxis, Inc. | 2.15 Million USD | -4368.3% |
| Seelos Therapeutics, Inc. | 2.14 Million USD | -4390.587% |
| Lumos Pharma, Inc. | 2 Million USD | -4701.594% |
| Achilles Therapeutics plc | -4.73 Million USD | 2136.833% |
| enGene Holdings Inc. Common Stock | -175 Thousand USD | 55167.429% |
| 180 Life Sciences Corp. | -105.67 Thousand USD | 91292.808% |
| Opiant Pharmaceuticals, Inc. | 31.65 Million USD | -204.396% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | -11078.221% |
| ORIC Pharmaceuticals, Inc. | -1.03 Million USD | 9437.984% |
| CG Oncology, Inc. Common stock | -45.54 Million USD | 311.575% |
| Fractyl Health, Inc. Common Stock | 43 Thousand USD | -224011.628% |
| Rani Therapeutics Holdings, Inc. | -822 Thousand USD | 11823.601% |
| MoonLake Immunotherapeutics | -13.15 Thousand USD | 732490.941% |
| Palisade Bio, Inc. | 246 Thousand USD | -39073.984% |
| Tourmaline Bio, Inc. | -33 Thousand USD | 292124.242% |
| Beam Therapeutics Inc. | -59.67 Million USD | 261.496% |
| Neurogene Inc. | -3.26 Million USD | 3054.261% |
| Mirum Pharmaceuticals, Inc. | 139.33 Million USD | 30.837% |
| AEON Biopharma, Inc. | - USD | -Infinity% |
| CARGO Therapeutics, Inc. Common Stock | -3.69 Million USD | 2710.184% |
| Sesen Bio, Inc. | 40 Million USD | -140.92% |
| Enliven Therapeutics, Inc. | -297 Thousand USD | 32547.138% |
| Kiora Pharmaceuticals, Inc. | -4.02 Million USD | 2493.025% |
| Iovance Biotherapeutics, Inc. | -9.56 Million USD | 1107.401% |
| Taysha Gene Therapies, Inc. | 14.08 Million USD | -584.432% |
| Athira Pharma, Inc. | -969 Thousand USD | 10045.098% |
| Vaccinex, Inc. | -16 Million USD | 702.149% |
| HCW Biologics Inc. | -574.82 Thousand USD | 16864.784% |
| XOMA Corporation | 3.86 Million USD | -2395.934% |
| Nektar Therapeutics | 53.47 Million USD | -80.201% |
| Arvinas, Inc. | 71.8 Million USD | -34.217% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Merus N.V. | -83.46 Million USD | 215.465% |
| Omega Therapeutics, Inc. | -62.77 Million USD | 253.513% |
| Quince Therapeutics, Inc. | -322 Thousand USD | 30027.95% |
| Rezolute, Inc. | -36 Thousand USD | 267788.889% |
| Clene Inc. | 533 Thousand USD | -17980.3% |
| Indaptus Therapeutics, Inc. | -1284.00 USD | 7505395.95% |
| BeyondSpring Inc. | 1.75 Million USD | -5403.598% |
| Synlogic, Inc. | -1.92 Million USD | 5108.732% |
| Allarity Therapeutics, Inc. | -37 Thousand USD | 260554.054% |
| Phio Pharmaceuticals Corp. | -6.33 Million USD | 1621.92% |
| Peak Bio, Inc. | 367.76 Thousand USD | -26103.405% |
| Werewolf Therapeutics, Inc. | -18.96 Million USD | 608.19% |
| Krystal Biotech, Inc. | 47.6 Million USD | -102.433% |
| Karyopharm Therapeutics Inc. | 141.09 Million USD | 31.698% |
| SpringWorks Therapeutics, Inc. | 5.02 Million USD | -1817.771% |
| Lipella Pharmaceuticals Inc. | -2.58 Million USD | 3821.895% |
| MannKind Corporation | 136.19 Million USD | 29.241% |
| Ikena Oncology, Inc. | -50.49 Million USD | 290.858% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 108.81 Million USD | 11.438% |
| Gossamer Bio, Inc. | -4.38 Million USD | 2297.674% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | -252 Thousand USD | 38341.27% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 1927460.0% |
| Legend Biotech Corporation | 140.92 Million USD | 31.619% |
| Mural Oncology plc | -2.56 Million USD | 3854.11% |
| Biora Therapeutics, Inc. | -551 Thousand USD | 17589.655% |
| PaxMedica, Inc. Common Stock | - USD | -Infinity% |
| Disc Medicine, Inc. | -100 Thousand USD | 96468.0% |
| Champions Oncology, Inc. | 20.75 Million USD | -364.335% |
| REGENXBIO Inc. | 53.02 Million USD | -81.727% |
| Ensysce Biosciences, Inc. | -5.35 Million USD | 1898.933% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | -192.37 Thousand USD | 50193.827% |
| Edgewise Therapeutics, Inc. | -1.73 Million USD | 5663.972% |
| Vaxart, Inc. | -60.76 Million USD | 258.597% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | -262.78 Thousand USD | 36772.502% |
| Cellectis S.A. | 18 Thousand USD | -535277.778% |
| Longeveron Inc. | 221 Thousand USD | -43505.43% |
| Repare Therapeutics Inc. | -80.07 Million USD | 220.355% |
| Sarepta Therapeutics, Inc. | 1.09 Billion USD | 91.183% |
| Inozyme Pharma, Inc. | -1.29 Million USD | 7547.295% |
| Revolution Medicines, Inc. | -399.66 Million USD | 124.112% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| Third Harmonic Bio, Inc. | -35 Thousand USD | 275437.143% |
| ArriVent BioPharma, Inc. Common Stock | - USD | -Infinity% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 49 Thousand USD | -196569.388% |
| Vertex Pharmaceuticals Incorporated | 8.6 Billion USD | 98.88% |
| Denali Therapeutics Inc. | -93.34 Million USD | 203.239% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 384817.953% |
| Veru Inc. | 7.56 Million USD | -1173.71% |
| Corvus Pharmaceuticals, Inc. | -151 Thousand USD | 63919.868% |
| Cingulate Inc. | -582.91 Thousand USD | 16631.999% |
| Passage Bio, Inc. | -3.72 Million USD | 2689.841% |
| Context Therapeutics Inc. | -12.04 Thousand USD | 800232.846% |
| Exicure, Inc. | -1.42 Million USD | 6872.171% |
| Day One Biopharmaceuticals, Inc. | -383 Thousand USD | 25261.358% |
| Oramed Pharmaceuticals Inc. | 2.7 Million USD | -3465.224% |
| Scinai Immunotherapeutics Ltd. | -512.67 Thousand USD | 18897.094% |
| Rhythm Pharmaceuticals, Inc. | 68.12 Million USD | -41.456% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | -149.6 Thousand USD | 64514.098% |
| Carisma Therapeutics, Inc. | -59.2 Million USD | 262.767% |
| Unicycive Therapeutics, Inc. | 391 Thousand USD | -24546.547% |
| OmniAb, Inc. | 14.66 Million USD | -557.04% |
| Anew Medical, Inc. | - USD | -Infinity% |
| Fennec Pharmaceuticals Inc. | 19.99 Million USD | -382.009% |
| Lipocine Inc. | -2.85 Million USD | 3480.363% |
| Lexeo Therapeutics, Inc. Common Stock | -1.84 Million USD | 5328.866% |
| Nautilus Biotechnology, Inc. | -5.7 Million USD | 1789.185% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 6497.701% |
| G1 Therapeutics, Inc. | 75.31 Million USD | -27.952% |
| Bellerophon Therapeutics, Inc. | -65 Thousand USD | 148358.462% |
| Sage Therapeutics, Inc. | 84.29 Million USD | -14.321% |
| Ocugen, Inc. | -33.53 Million USD | 387.348% |
| Mind Medicine (MindMed) Inc. | -3.16 Million USD | 3147.691% |
| Q32 Bio Inc. | 578 Thousand USD | -16572.664% |
| Brainstorm Cell Therapeutics Inc. | -265 Thousand USD | 36465.283% |
| Alumis Inc. Common Stock | -1.28 Million USD | 7605.296% |
| Equillium, Inc. | 35.95 Million USD | -168.002% |
| Kyverna Therapeutics, Inc. | -1.7 Million USD | 5745.46% |
| Coya Therapeutics, Inc. | 500.67 Thousand USD | -19147.462% |
| CNS Pharmaceuticals, Inc. | -4134.00 USD | 2331207.886% |
| Galera Therapeutics, Inc. | -259 Thousand USD | 37307.722% |
| Evelo Biosciences, Inc. | - USD | -Infinity% |
| Comera Life Sciences Holdings, Inc. | 422.71 Thousand USD | -22697.555% |
| Dominari Holdings Inc. | 2.03 Million USD | -4626.238% |
| Edesa Biotech, Inc. | -183.47 Thousand USD | 52624.922% |
| vTv Therapeutics Inc. | -13.59 Million USD | 808.849% |
| Bio-Techne Corporation | 773.07 Million USD | 87.534% |
| Agios Pharmaceuticals, Inc. | 17.31 Million USD | -456.429% |
| Harmony Biosciences Holdings, Inc. | 460.78 Million USD | 79.086% |
| Prelude Therapeutics Incorporated | -1.16 Million USD | 8343.627% |
| Candel Therapeutics, Inc. | -23.98 Million USD | 501.868% |
| iTeos Therapeutics, Inc. | 11.69 Million USD | -723.869% |
| Nkarta, Inc. | -5.86 Million USD | 1741.983% |
| BioCardia, Inc. | -7.24 Million USD | 1429.397% |
| Iterum Therapeutics plc | -1.75 Million USD | 5606.743% |